Shalini Sharp - Net Worth and Insider Trading

Shalini Sharp Net Worth

The estimated net worth of Shalini Sharp is at least $4 Million dollars as of 2024-04-24. Shalini Sharp is the EVP, Finance of Ultragenyx Pharmaceutical Inc and owns about 97,812 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $4 Million. Shalini Sharp is also the Director of Agenus Inc and owns about 4,066 shares of Agenus Inc (AGEN) stock worth over $30,170. Details can be seen in Shalini Sharp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shalini Sharp has not made any transactions after 2020-10-14 and currently still holds the listed stock(s).

Transaction Summary of Shalini Sharp

To

Shalini Sharp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shalini Sharp owns 9 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Panacea Acquisition Corp (PANA.U) , and Sutro Biopharma Inc (STRO) among others .

Click here to see the complete history of Shalini Sharp’s form 4 insider trades.

Insider Ownership Summary of Shalini Sharp

Ticker Comapny Transaction Date Type of Owner
RARE Ultragenyx Pharmaceutical Inc 2020-10-14 CFO & Senior Vice President
PANA.U Panacea Acquisition Corp 2020-06-30 director
STRO Sutro Biopharma Inc 2018-11-08 director
DTIL Precision BioSciences Inc 2019-03-27 director
NBIX Neurocrine Biosciences Inc 2020-02-01 director
AGEN Agenus Inc 2016-09-16 director
MRTX Mirati Therapeutics Inc 2021-03-26 director
NUVB Nuvation Bio Inc 2020-06-30 director
OGN Organon & Co 2021-05-14 director

Shalini Sharp Latest Holdings Summary

Shalini Sharp currently owns a total of 2 stocks. Among these stocks, Shalini Sharp owns 97,812 shares of Ultragenyx Pharmaceutical Inc (RARE) as of October 14, 2020, with a value of $4 Million and a weighting of 99.31%. Shalini Sharp also owns 4,066 shares of Agenus Inc (AGEN) as of January 30, 2013, with a value of $30,170 and a weighting of 0.69%.

Latest Holdings of Shalini Sharp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RARE Ultragenyx Pharmaceutical Inc 2020-10-14 97,812 44.28 4,331,115
AGEN Agenus Inc 2013-01-30 4,066 7.42 30,170

Holding Weightings of Shalini Sharp


Shalini Sharp Form 4 Trading Tracker

According to the SEC Form 4 filings, Shalini Sharp has made a total of 4 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 375 shares on October 14, 2020, which brought Shalini Sharp around $32,996.

According to the SEC Form 4 filings, Shalini Sharp has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 14 shares on January 30, 2013, which brought Shalini Sharp around $1,256.

Insider Trading History of Shalini Sharp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shalini Sharp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shalini Sharp Ownership Network

Ownership Network List of Shalini Sharp

No Data

Ownership Network Relation of Shalini Sharp


Shalini Sharp Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?

Who are the key executives at Ultragenyx Pharmaceutical Inc?

Shalini Sharp is the CFO & Senior Vice President of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .

Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary

Over the past 18 months, Shalini Sharp made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .

In summary, during the past 3 months, insiders sold 69,133 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 69,133 shares. During the past 18 months, 243,293 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,293 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ultragenyx Pharmaceutical Inc Insider Transactions

No Available Data

Shalini Sharp Mailing Address

Above is the net worth, insider trading, and ownership report for Shalini Sharp. You might contact Shalini Sharp via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.

Discussions on Shalini Sharp

No discussions yet.